Indoco Remedies Q2 Results: Net profit at ₹19.5 Crore, revenue rises 7%

Shares of Indoco Remedies Ltd. were trading over 3% higher on Tuesday, October 27, after the pharmaceutical company reported a return to profitability in the second quarter of FY27, along with growth in revenue and EBITDA.

Indoco Remedies

reported a net profit of ₹19.5 crore for the quarter, compared with a net loss of ₹9.2 crore in the corresponding period last year.

Revenue from operations increased 7.4% year-on-year to ₹507 crore, from ₹472 crore in the year-ago quarter. EBITDA rose 10% to ₹33 crore, compared with ₹30.2 crore in the same period last year.

The company’s EBITDA margin improved marginally to 6.5% from 6.4% a year earlier.

Following the results, Indoco Remedies shares were trading 3.42% higher at ₹227 on Tuesday. Despite the day’s gains, the stock remains down around 1% so far in 2026.